Nancy J. Sullivan, Ebola Vaccine and Treatment Pioneer, Named New NEIDL Director
Says priorities will include global engagement, strong science, and diversity, equity, and inclusion.
New Targets to Treat Type 1 Diabetes
Chemist Arturo Vegas wins $1.4 million NIH grant to develop therapies that intervene at early stage of disease Arturo Vegas wants to create novel therapies that will either suppress rogue immune cells attacking the pancreas of people with type 1 diabetes or strengthen the pancreas’ defenses against the rogue cells. Photo courtesy of Arturo Vegas. […]